FDA Medication Shortages: What Does it Means?

What Causes Drug Shortages?

Drug shortages are rarely caused by a single issue. Instead, they often result from a combination of factors affecting the drug supply chain. Some of the most common causes include:

Manufacturing and Quality Issues: Problems with good manufacturing practices can lead to delays or shutdowns, resulting in supply disruptions.

Supply Chain Vulnerabilities: Delays in sourcing active pharmaceutical ingredients (API), inactive ingredients, or sterile injectable components can slow production.

Unexpected Demand Surges: Public health emergencies like the COVID-19 pandemic, shifts in treatment guidelines, or increased off-label use can rapidly deplete available supplies.

Discontinuations: Some drug manufacturers stop producing certain drug products, often due to low profitability. The FDA cannot mandate production, but it works to identify alternative sources.

Shipping and Distribution Delays: Logistics bottlenecks, geopolitical events, or regulatory changes can disrupt the delivery of prescription drugs.

Certain therapies, especially sterile injectable drugs, are at higher risk of shortages due to their complex manufacturing processes and limited number of producers.

The Impact of Drug Shortages on Healthcare

The consequences of drug shortages extend beyond pharmacies. They affect every level of medical care:

For Patients: Shortages can result in treatment delays, the need for alternative drug therapies, and, in severe cases, significant public health risks.

 For Healthcare Providers: Physicians and pharmacists must navigate short supply by identifying substitutes, adjusting dosages, and coordinating patient care under supply issues.

For the Healthcare System: Shortages increase medical costs, strain hospital resources, and can contribute to medication errors when less familiar drugs are used.

The FDA drug shortage information platform helps healthcare professionals stay informed, but navigating shortages still requires adaptability and proactive planning.

How the FDA Mitigates Drug Shortages

The FDA’s Center for Drug Evaluation and Research (CDER), along with the Department of Health and Human Services (HHS), takes a multi-pronged approach to address and prevent drug shortages:

Drug Shortages Database: The FDA drug shortages database provides up-to-date information on ongoing supply issues, alternative drugs, and manufacturer updates.

Manufacturer Collaboration: The FDA works with drug manufacturers to resolve quality issues, expand production, or identify FDA-approved substitutes.

Expiration Date Extensions: To maximize supply, the FDA may authorize extended shelf life for certain medications when data supports their continued safety and efficacy.

Foreign Drug Sourcing: When necessary, the FDA facilitates the importation of FDA-approved drugs from foreign suppliers to alleviate shortages.

Compounding During Shortages: In cases where an FDA-approved medication is unavailable, compounding may serve as a temporary alternative. However, compounded drugs do not undergo the same FDA approval process.

Example: The recent shortage of semaglutide-based drugs (e.g., Ozempic, Wegovy, and Mounjaro) led to a surge in compounded versions, giving LookMeds a chance to provide semaglutide and tirzepatide to those who need it at a much more affordable setting.

Tip: Patients should consult their healthcare providers before using compounded drugs and ensure they are sourced from a reputable, licensed compounding pharmacy. 

Check if you qualify for compounded medications.

What Can Patients and Healthcare Providers Do?

If you’re facing difficulty accessing your medication, here’s how you can navigate the drug shortage landscape:

Check the FDA’s Drug Shortage Database: Visit FDA.gov to see if your medication is listed as a current drug shortage.

Consult Multiple Pharmacies: Some shortages are regional rather than nationwide. One pharmacy may have supply while another does not.

Talk to Your Doctor or Pharmacist: If your medication is unavailable, your healthcare provider can recommend an alternative drug or adjust your treatment plan.

Report New Shortages: If you encounter supply issues not listed on the FDA drug shortage list, report them through the FDA’s public portal.

Be Cautious with Compounded Drugs: If you find compounded drugs are right for you, ensure you’re working with a reputable provider that follows state guidelines. Use these medications under the supervision of a healthcare professional.

‍

Bottom Line

Drug shortages pose an ongoing challenge to patient care and public health, requiring coordinated action from drug manufacturers, regulatory agencies, distributors, and healthcare professionals.

The FDA, alongside organizations like ASHP, remains committed to monitoring new drug shortages, promoting transparency, and ensuring that healthcare providers and patients have access to accurate drug shortage information.

By staying informed, advocating for supply chain resilience, and utilizing available resources, stakeholders across the healthcare industry can work together to minimize the impact of shortages and maintain the integrity of medical care.

For real-time updates, visit FDA.gov and consult the FDA Drug Shortages Database.